"Lypressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
| Descriptor ID |
D008236
|
| MeSH Number(s) |
D06.472.699.631.692.781.400 D12.644.400.900.400 D12.644.456.925.480 D12.644.548.691.692.781.400 D12.776.631.650.937.400
|
| Concept/Terms |
Lypressin- Lypressin
- 8-Lysine Vasopressin
- 8 Lysine Vasopressin
- Vasopressin, 8-Lysine
- Lysyl Vasopressin
- Vasopressin, Lysyl
- Lys-Vasopressin
- Lys Vasopressin
- Lysine Vasopressin
- Vasopressin, Lysine
|
Below are MeSH descriptors whose meaning is more general than "Lypressin".
Below are MeSH descriptors whose meaning is more specific than "Lypressin".
This graph shows the total number of publications written about "Lypressin" by people in this website by year, and whether "Lypressin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lypressin" by people in Profiles.
-
Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 2024 04 01; 30(4):347-355.
-
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome. Kidney360. 2023 08 01; 4(8):1030-1038.
-
Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3455-3457.e3.
-
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther. 2022 10; 56(8):1284-1293.
-
Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 07; 16(7):1174.
-
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Aliment Pharmacol Ther. 2017 06; 45(11):1390-1402.
-
Terlipressin Improves Renal Function and Reverses Hepatorenal?Syndrome in Patients With Systemic Inflammatory?Response?Syndrome. Clin Gastroenterol Hepatol. 2017 02; 15(2):266-272.e1.
-
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Gastroenterology. 2016 Jun; 150(7):1579-1589.e2.
-
Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Database Syst Rev. 2013 Mar 28; (3):CD009171.
-
Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis. Int Urol Nephrol. 2011 Mar; 43(1):175-84.